P-COMM-B induction chemotherapy in intermediate and high grade non-Hodgkin's lymphoma

Leukemia & Lymphoma
J K PhillipsJ C Cawley

Abstract

57 patients with newly diagnosed intermediate or high grade non-Hodgkin's lymphoma with stage II to IV disease were treated with P-COMM-B (prednisolone, cyclophosphamide, vincristine, mitozantrone, methotrexate and bleomycin). 46% patients achieved a complete remission and 26% achieved a partial remission. Projected disease-free survival in complete remission at 5 years is 56% and projected overall survival at 5 years is 37%. Neutropenia and proximal myopathy were the commonest severe toxicities encountered and two deaths were clearly related to treatment (3.5%). P-COMM-B is effective first-line chemotherapy in intermediate and high grade non-Hodgkin's lymphoma. The efficacy and toxicity of P-COMM-B appear to be comparable to those of the best contemporary regimen, CHOP.

References

Jan 1, 1977·Acta Anatomica·F A StateA A Bondok
Mar 1, 1992·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S PavlovskyH Magnasco
Jan 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A M SchneiderB D Clarkson
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J K WeickH I Pierce
Jan 1, 1991·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J O Armitage
Oct 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S E JonesL Dabich
Jun 1, 1967·Annals of Internal Medicine·T C HallM J Krant

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.